A Multi-Drug Concentration Gradient Mixing Chip: A Novel Platform for High-Throughput Drug Combination Screening

Jiahao Fu,Yibo Feng,Yu Sun,Ruiya Yi,Jing Tian,Wei Zhao,Dan Sun,Ce Zhang

DOI: https://doi.org/10.3390/bios14050212

2024-04-24

Biosensors

Abstract:Combinatorial drug therapy has emerged as a critically important strategy in medical research and patient treatment and involves the use of multiple drugs in concert to achieve a synergistic effect. This approach can enhance therapeutic efficacy while simultaneously mitigating adverse side effects. However, the process of identifying optimal drug combinations, including their compositions and dosages, is often a complex, costly, and time-intensive endeavor. To surmount these hurdles, we propose a novel microfluidic device capable of simultaneously generating multiple drug concentration gradients across an interlinked array of culture chambers. This innovative setup allows for the real-time monitoring of live cell responses. With minimal effort, researchers can now explore the concentration-dependent effects of single-agent and combination drug therapies. Taking neural stem cells (NSCs) as a case study, we examined the impacts of various growth factors—epithelial growth factor (EGF), platelet-derived growth factor (PDGF), and fibroblast growth factor (FGF)—on the differentiation of NSCs. Our findings indicate that an overdose of any single growth factor leads to an upsurge in the proportion of differentiated NSCs. Interestingly, the regulatory effects of these growth factors can be modulated by the introduction of additional growth factors, whether singly or in combination. Notably, a reduced concentration of these additional factors resulted in a decreased number of differentiated NSCs. Our results affirm that the successful application of this microfluidic device for the generation of multi-drug concentration gradients has substantial potential to revolutionize drug combination screening. This advancement promises to streamline the process and accelerate the discovery of effective therapeutic drug combinations.

chemistry, analytical,nanoscience & nanotechnology,instruments & instrumentation

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is **the problem of screening the best drug combinations and their dosages in combination drug therapy**. Specifically, traditional combination drug screening methods are time - consuming, costly and complex, while this paper proposes a new microfluidic device that can simultaneously generate multiple drug concentration gradients and achieve real - time monitoring of living cell responses. This innovative device can efficiently explore the concentration - dependent effects of single - drug and combination - drug therapies, especially for the differentiation influence of neural stem cells (NSCs) under the action of different growth factors (such as epidermal growth factor EGF, platelet - derived growth factor PDGF and fibroblast growth factor FGF). The study found that an excess of a single growth factor will lead to an increase in NSCs differentiation, and by introducing other growth factors, this differentiation effect can be regulated, thus providing a new and efficient platform for combination drug screening.

A Multi-Drug Concentration Gradient Mixing Chip: A Novel Platform for High-Throughput Drug Combination Screening

A microfluidic dual gradient generator for conducting cell-based drug combination assays

High-throughput 3D microfluidic chip for generation of concentration gradients and mixture combinations

Construction of Multiple Concentration Gradients for Single-Cell Level Drug Screening

An On-Chip Cell Culturing and Combinatorial Drug Screening System

A concentration gradient generator on a paper-based microfluidic chip coupled with cell culture microarray for high-throughput drug screening

Multi-layered Microfluidic Drug Screening Platform Enabling Simultaneous Generation of Linear and Logarithmic Concentration Gradients

Parallel Microfluidic Networks for Studying Cellular Response to Chemical Modulation

3D Printed Microfluidic Chip for Multiple Anticancer Drug Combinations

High-throughput Single Cell Multidrug Resistance Analysis with Multifunctional Gradients-Customizing Microfluidic Device

Cell spheroids culture array with modifiable chemical gradients

A New Circular-Shape Microfluidic Network for Generating Gradients of Multiple Substances -Design, Demonstration and Application

A Plug-and-Play, Drug-on-Pillar Platform for Combination Drug Screening Implemented by Microfluidic Adaptive Printing

A Microfluidic Droplet Array System for Cell-Based Drug Combination Screening

A Programmable Microfluidic Cell Array for Combinatorial Drug Screening.

An Integrated Microfluidics Platform with High-Throughput Single-Cell Cloning Array and Concentration Gradient Generator for Efficient Cancer Drug Effect Screening.

A versatile dilution-treatment-detection microfluidic chip platform for rapid In vitro lung cancer drug combination sensitivity evaluation

Application of a Microfluidic Chip-Based 3D Co-Culture to Test Drug Sensitivity for Individualized Treatment of Lung Cancer.

A high-throughput, open-space and reusable microfluidic chip for combinational drug screening on tumor spheroids

Micro-scaffold array chip for upgrading cell-based high-throughput drug testing to 3D using benchtop equipment.

Microfluidic-Enabled Print-to-Screen Platform for High-Throughput Screening of Combinatorial Chemotherapy